Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  V.TLT.WT | TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Bullboard Posts
Comment by macman1519on Jan 27, 2018 3:17pm
52 Views
Post# 27447606

RE:RE:RE:Why would you find it strange?

RE:RE:RE:Why would you find it strange?Well, this tells u that frostie is out of the immediate picture as a white knight. He could not be buying his own stock if a deal with us is imminent!!!!!!! Now Roger has bought shittttt of his own stock even at these redicuously low numbers for over a year???? !!! Another solid move by Rooger showing faith in his own FRIGGIN company, please get pharma on board so we have some help for mom and pop!!!! quote=macman1519]
Pandora wrote: From MarketReady:
  • Opko Health Inc. (NASDAQ:OPK) CEO Phillip Md Et Al Frost purchased 100,000 shares of the company's stock in a transaction on Monday, January 22nd. The stock was purchased at an average cost of $4.40 per share, for a total transaction of $440,000.00. Following the purchase, the chief executive officer now directly owns 3,068,951 shares in the company, valued at $13,503,384.40. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. This trade was viewed 101 times. Read More.
  • Opko Health Inc. (NASDAQ:OPK) CEO Phillip Md Et Al Frost bought 100,000 shares of the stock in a transaction that occurred on Wednesday, January 24th. The stock was bought at an average cost of $4.89 per share, for a total transaction of $489,000.00. Following the transaction, the chief executive officer now owns 3,068,951 shares of the company's stock, valued at approximately $15,007,170.39. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. This trade was viewed 87 times. Read More.


[/quote]

Bullboard Posts